<div id="readability-page-1"><div><p>(MT Newswires) -- Eyebright Medical Technology (Beijing) (SHA:688050) obtained market registration approval from China's medical products administrator for its extended depth of focus intraocular lens.</p><p> The product is intended for vision correction after adult cataract surgery, according to a filing with the Shanghai bourse.</p><p>Shares of the medical device manufacturer closed 2% higher Monday.</p></div></div>

愛博醫療

<p>（MT Newswires）-- 愛博醫療科技（北京）（SHA:688050）獲得中國醫療產品管理局對其延伸焦深人工晶體的市場註冊批准。根據上海證券交易所的文件，該產品旨在用於成人白內障手術後的視力矯正。該醫療器械製造商的股票週一收盤上漲 2%</p>

愛博醫療科技獲得了人工晶狀體的市場準入許可